Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2023-07-17FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
The FDA approved a supplemental application for TEPEZZA (teprotumumab) from Horizon Therapeutics USA, Inc., indicating a labeling update.